These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9734617)

  • 41. Efficacy of oral citrate administration in primary hyperoxaluria.
    Leumann E; Hoppe B; Neuhaus T; Blau N
    Nephrol Dial Transplant; 1995; 10 Suppl 8():14-6. PubMed ID: 8592618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liver cell transplantation in severe infantile oxalosis--a potential bridging procedure to orthotopic liver transplantation?
    Beck BB; Habbig S; Dittrich K; Stippel D; Kaul I; Koerber F; Goebel H; Salido EC; Kemper M; Meyburg J; Hoppe B
    Nephrol Dial Transplant; 2012 Jul; 27(7):2984-9. PubMed ID: 22287658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperoxaluria: a gut-kidney axis?
    Robijn S; Hoppe B; Vervaet BA; D'Haese PC; Verhulst A
    Kidney Int; 2011 Dec; 80(11):1146-58. PubMed ID: 21866092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of isolated kidney transplantation in a pediatric patient with primary hyperoxaluria type 2.
    Naderi G; Latif A; Tabassomi F; Esfahani ST
    Pediatr Transplant; 2014 May; 18(3):E69-73. PubMed ID: 24597735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Assessment of oxalate concentration in serum and urine of children with renal stones].
    Jadeszko I; Porowski T; Zoch-Zwierz WM; Wasilewska AM; Hackiewicz L
    Wiad Lek; 2005; 58 Suppl 1():20-4. PubMed ID: 16060079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.
    Milliner DS; Cochat P; Hulton SA; Harambat J; Banos A; Dehmel B; Lindner E
    Pediatr Nephrol; 2021 Jul; 36(7):1785-1793. PubMed ID: 33515281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Secondary oxalosis following small bowel resection with kidney insufficiency and oxalate vasculopathy].
    Kiss D; Meier R; Gyr K; Wegmann W
    Schweiz Med Wochenschr; 1992 May; 122(22):854-7. PubMed ID: 1604291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Primary hyperoxaluria].
    Toussaint C; De Pauw L
    Nephrologie; 1995; 16(6):399-406. PubMed ID: 8524446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure.
    Worcester EM; Nakagawa Y; Bushinsky DA; Coe FL
    J Clin Invest; 1986 Jun; 77(6):1888-96. PubMed ID: 3711339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Chetyrkin SV; Kim D; Belmont JM; Scheinman JI; Hudson BG; Voziyan PA
    Kidney Int; 2005 Jan; 67(1):53-60. PubMed ID: 15610227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Adult type I primary hyperoxaluria: 2 cases confirmed by liver biopsy at end-stage renal insufficiency].
    Schillinger F; Mahmoud M; Montagnac R; Collin P; Milcent T
    Nephrologie; 1990; 11(4):217-21. PubMed ID: 2074921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone impairment in oxalosis: An ultrastructural bone analysis.
    Bacchetta J; Farlay D; Abelin-Genevois K; Lebourg L; Cochat P; Boivin G
    Bone; 2015 Dec; 81():161-167. PubMed ID: 26164477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation--are they inter-related?
    Sebeková K; Podracká L; Heidland A; Schinzel R
    Clin Nephrol; 2001 Dec; 56(6):S21-6. PubMed ID: 11770807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.
    D'Costa MR; Winkler NS; Milliner DS; Norby SM; Hickson LJ; Lieske JC
    Am J Kidney Dis; 2019 Sep; 74(3):417-420. PubMed ID: 30910370
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic liver disease and hepatic calcium-oxalate deposition in patients with primary hyperoxaluria type I.
    Recker P; Beck BB; Sikora P; Göbel H; Kemper MJ; Nazco A; Martin-Higueras C; Hoppe B
    Sci Rep; 2022 Oct; 12(1):16725. PubMed ID: 36202824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary calcium oxalate saturation in healthy infants and children.
    Hoppe B; Jahnen A; Bach D; Hesse A
    J Urol; 1997 Aug; 158(2):557-9. PubMed ID: 9224359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary lithogenic risk profile in recurrent stone formers with hyperoxaluria: a randomized controlled trial comparing DASH (Dietary Approaches to Stop Hypertension)-style and low-oxalate diets.
    Noori N; Honarkar E; Goldfarb DS; Kalantar-Zadeh K; Taheri M; Shakhssalim N; Parvin M; Basiri A
    Am J Kidney Dis; 2014 Mar; 63(3):456-63. PubMed ID: 24560157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B; Groothoff JW; Hulton SA; Cochat P; Niaudet P; Kemper MJ; Deschênes G; Unwin R; Milliner D
    Nephrol Dial Transplant; 2011 Nov; 26(11):3609-15. PubMed ID: 21460356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.